Mike Mackness
University of Manchester · 242 works · 18,983 citations · h-index 63
Top works
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
- Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
- Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India
- The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
- Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins
- Paraoxonase and Atherosclerosis
- HDL, its enzymes and its potential to influence lipid peroxidation
- Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins
- Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification
- Paraoxonase Status in Coronary Heart Disease
- Human Serum Paraoxonase
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon
- Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study
- Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations
- Paraoxonase and coronary heart disease
- Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation
- Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes